Table 1. Baseline characteristics of patients with TB pleurisy.
Variables | Total (N=367) | GPS 0 (n=119) | GPS 1 (n=198) | GPS 2 (n=50) | P value |
---|---|---|---|---|---|
Age (year) | 49.5±21.5 | 46.0±19.4 | 48.9±21.3 | 60.1±23.9 | <0.001 |
Males | 209 (56.9) | 65 (54.6) | 118 (59.6) | 26 (52.0) | 0.515 |
BMI | 21.6±3.3 | 21.9±2.8 | 21.5±3.7 | 20.8±3.2 | 0.158 |
Smoking | |||||
Current smoker | 78 (21.3) | 20 (16.8) | 49 (24.7) | 9 (18.0) | 0.205 |
Ex-smoker | 45 (12.3) | 11 (9.2) | 31 (15.7) | 3 (6.0) | 0.084 |
PYs | 23.9±20.4 | 20.6±17.2 | 24.6±21.7 | 28.2±20.2 | 0.509 |
Underlying disease | |||||
DM | 29 (7.9) | 4 (3.4) | 18 (9.1) | 7 (14.0) | 0.043 |
COPD | 4 (1.1) | 2 (1.7) | 2 (1.0) | 0 (0.0) | 0.623 |
Other malignancy | 11 (3.0) | 3 (2.5) | 7 (3.5) | 1 (2.0) | 0.794 |
LC | 4 (1.1) | 1 (0.8) | 3 (1.5) | 0 (0.0) | 0.621 |
Autoimmune disease | 4 (1.1) | 1 (0.8) | 3 (1.5) | 0 (0.0) | 0.621 |
Post-transplantation | 1 (0.3) | 1 (0.8) | 0 (0.0) | 0 (0.0) | 0.352 |
ESRD | 3 (0.8) | 1 (0.8) | 2 (1.0) | 0 (0.0) | 0.777 |
History of TB | 50 (13.6) | 12 (10.1) | 28 (14.1) | 10 (20.0) | 0.219 |
Symptoms | |||||
Dyspnea | 142 (38.7) | 38 (31.9) | 84 (42.4) | 20 (40.0) | 0.175 |
Chest pain | 176 (48.0) | 61 (51.3) | 95 (48.0) | 20 (40.0) | 0.409 |
Cough | 73 (19.9) | 28 (23.5) | 31 (15.7) | 14 (28.0) | 0.071 |
Fever | 48 (13.1) | 12 (10.1) | 27 (13.6) | 9 (18.0) | 0.357 |
General weakness | 7 (1.9) | 2 (1.7) | 5 (2.5) | 0 (0.0) | 0.494 |
Weight loss | 11 (3.0) | 4 (3.4) | 5 (2.5) | 2 (4.0) | 0.827 |
Hemoptysis | 4 (1.1) | 3 (2.5) | 1 (0.5) | 0 (0.0) | 0.179 |
Effusion site | 0.427 | ||||
Right | 225 (61.3) | 76 (63.9) | 118 (59.6) | 31 (62.0) | |
Left | 135 (36.8) | 43 (36.1) | 74 (37.4) | 18 (36.0) | |
Bilateral | 7 (1.9) | 0 (0.0) | 6 (3.0) | 1 (2.0) | |
Accompanied PTB | 141 (38.4) | 43 (36.1) | 81 (40.9) | 17 (34) | 0.505 |
Data are presented as n (%) or mean ± SD. GPS, Glasgow Prognostic Score; BMI, body mass index; PYs, pack years; DM, diabetes mellitus; COPD, chronic obstructive pulmonary disease; LC, liver cirrhosis; ESRD, end stage renal disease; TB, tuberculosis; PTB, pulmonary tuberculosis.